Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5-Lipoxygenase-activating protein (FLAP) is an integral membrane protein essential for the biosynthesis of leukotrienes. It acts as a membrane anchor for the enzyme 5-lipoxygenase (ALOX5) and facilitates the conversion of arachidonic acid to leukotrienes, which are lipid mediators involved in inflammation and play significant roles in respiratory, cardiovascular, and metabolic diseases.
Inhibition of leukotriene synthesis by preventing arachidonic acid presentation to 5-lipoxygenase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-Lipoxygenase-Activating Protein (FLAP).